BriaCell Therapeutics Corp. (BCTX)

BriaCell Therapeutics Statistics

Total Valuation

BCTX has a market cap or net worth of $23.16 million. The enterprise value is $4.88 million.

Market Cap	23.16M
Enterprise Value	4.88M

Important Dates

The next estimated earnings date is Friday, December 19, 2025, after market close.

Earnings Date	Dec 19, 2025
Ex-Dividend Date	n/a

Share Statistics

BCTX has 1.88 million shares outstanding. The number of shares has increased by 285.71% in one year.

Current Share Class	1.88M
Shares Outstanding	1.88M
Shares Change (YoY)	+285.71%
Shares Change (QoQ)	+134.79%
Owned by Insiders (%)	5.86%
Owned by Institutions (%)	4.12%
Float	1.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.34
P/TBV Ratio	1.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.01

Current Ratio	5.01
Quick Ratio	4.49
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-735.68

Financial Efficiency

Return on equity (ROE) is -362.56% and return on invested capital (ROIC) is -232.14%.

Return on Equity (ROE)	-362.56%
Return on Assets (ROA)	-123.56%
Return on Invested Capital (ROIC)	-232.14%
Return on Capital Employed (ROCE)	-153.95%
Revenue Per Employee	n/a
Profits Per Employee	-$1.64M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.92% in the last 52 weeks. The beta is 1.96, so BCTX's price volatility has been higher than the market average.

Beta (5Y)	1.96
52-Week Price Change	-92.92%
50-Day Moving Average	11.05
200-Day Moving Average	22.71
Relative Strength Index (RSI)	61.81
Average Volume (20 Days)	49,163

Short Selling Information

The latest short interest is 114,893, so 6.10% of the outstanding shares have been sold short.

Short Interest	114,893
Short Previous Month	129,157
Short % of Shares Out	6.10%
Short % of Float	6.86%
Short Ratio (days to cover)	1.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-27.20M
Pretax Income	-26.56M
Net Income	-26.31M
EBITDA	-27.10M
EBIT	-27.20M
Earnings Per Share (EPS)	-$62.19

Balance Sheet

The company has $17.87 million in cash and n/a in debt, giving a net cash position of $17.87 million or $9.48 per share.

Cash & Cash Equivalents	17.87M
Total Debt	n/a
Net Cash	17.87M
Net Cash Per Share	$9.48
Equity (Book Value)	17.33M
Book Value Per Share	9.49
Working Capital	15.95M

Cash Flow

Operating Cash Flow	-28.17M
Capital Expenditures	n/a
Free Cash Flow	-28.17M
FCF Per Share	-$14.95

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-285.71%
Shareholder Yield	-285.71%
Earnings Yield	-113.63%
FCF Yield	-121.66%

Analyst Forecast

The average price target for BCTX is $40.00, which is 224.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$40.00
Price Target Difference	224.54%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-66.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 25, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date	Aug 25, 2025
Split Type	Reverse
Split Ratio	1:10

Scores

Altman Z-Score	n/a
Piotroski F-Score	1